RBC Capital Remains a Buy on OmniAb (OABI)
TipRanksMay 1 09:49
RBC Capital Remains a Buy on OmniAb (OABI)
TipRanksApr 9 09:46
OmniAb Analyst Ratings
BenzingaMar 26 21:17
Truist Securities Maintains Buy on OmniAb, Maintains $10 Price Target
BenzingaMar 26 21:18
Craig-Hallum Sticks to Their Buy Rating for OmniAb (OABI)
TipRanksMar 25 22:25
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), OmniAb (OABI) and Vericel (VCEL)
TipRanksMar 25 09:40
OmniAb Analyst Ratings
BenzingaMar 23 01:30
Benchmark Co. Reaffirms Their Buy Rating on OmniAb (OABI)
TipRanksMar 22 19:18
OmniAb Analyst Ratings
BenzingaMar 21 23:08
OmniAb's Market Potential and Financial Stability Affirm Buy Rating
TipRanksMar 21 22:45
Stifel Nicolaus Sticks to Its Buy Rating for OmniAb (OABI)
TipRanksMar 21 19:27
Analysts Offer Insights on Healthcare Companies: Phreesia (PHR) and OmniAb (OABI)
TipRanksMar 21 19:10
OmniAb's Strategic Growth and Resilience Reinforce Buy Rating Amidst Q4 Revenue Shortfall
TipRanksMar 21 08:55
OmniAb (OABI) Receives a Buy From RBC Capital
TipRanksJan 27 09:47
RBC Initiates OmniAb at Outperform With $6 Price Target, Says Stock Gives Exposure to Growth Potential of Monoclonal Antibody Therapies
MT NewswiresNov 29, 2023 20:42
Benchmark Reiterates Buy on OmniAb, Maintains $8 Price Target
BenzingaNov 14, 2023 21:36
OmniAb Analyst Ratings
BenzingaNov 14, 2023 21:35
Benchmark Co. Reaffirms Their Buy Rating on OmniAb (OABI)
TipRanksNov 14, 2023 20:16
OmniAb's Strong Q3 Results and Ongoing Innovation Bolster Buy Rating: An Analysis by Leerink Partners
TipRanksNov 14, 2023 14:55
Analysts' Opinions Are Mixed on These Technology Stocks: Airgain (AIRG), OmniAb (OABI) and Par Technology (PAR)
TipRanksNov 11, 2023 01:10
No Data
No Data